Diagnosis and management of chronic ITP: comments from an ICIS expert group

Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert Meeting on...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of hematology 2010-07, Vol.89 (1), p.11-17
Hauptverfasser: Grainger, John David, Bolton-Maggs, Paula H. B, Godeau, Bertrand, Bussel, Jim, Donato, Hugo, Elalfy, Mohsen, Hainmann, Ina, Matzdorff, Axel, Müller-Beissenhirtz, Hannes, Rovó, Alicia, Tichelli, Andre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 17
container_issue 1
container_start_page 11
container_title Annals of hematology
container_volume 89
creator Grainger, John David
Bolton-Maggs, Paula H. B
Godeau, Bertrand
Bussel, Jim
Donato, Hugo
Elalfy, Mohsen
Hainmann, Ina
Matzdorff, Axel
Müller-Beissenhirtz, Hannes
Rovó, Alicia
Tichelli, Andre
description Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert Meeting on Consensus and Development of Strategies in ITP, held in Basel on September 3-5, 2009, a group of experts were tasked with reaching a consensus on some frequently asked questions relating to diagnosis and management of children and adults with chronic ITP. The content of this article is designed to provide a practical support to trained haematologists in their care of patients with chronic ITP.
doi_str_mv 10.1007/s00277-010-0950-0
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00612996v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2080619651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-a09fec23581604ee0235124f639c03806bffc8b02f1b61abc32fe1390586f0773</originalsourceid><addsrcrecordid>eNp9kcFvFCEUxomxsWv1D_CixJMeRt8DBgZvzartxk00aXsmDIXpNDvDCjtG_3uZTG0TD-UAL4_f98HLR8grhA8IoD5mAKZUBQgV6LpsT8gKBWcV1I14Slagua7qso7J85xvAZA1gj0jxwyE0Eo0K_Ltc2-7MeY-Uzte08GOtvODHw80BupuUhx7RzeXPz5RF4e5n2lIcSgw3aw3F9T_3vt0oF2K0_4FOQp2l_3Lu_OEXH39crk-r7bfzzbr023lhGKHyoIO3jFeNyhBeA-lRCaC5NoBb0C2IbimBRawlWhbx1nwyHUZSgZQip-Q94vvjd2ZfeoHm_6YaHtzfro1cw9AItNa_sLCvlvYfYo_J58PZuiz87udHX2cskHFGYdGNbPt2__Q2zilsUxiJGgtJApdIFwgl2LOyYf7DyCYORSzhGJKKGYOxUDRvL4zntrBX98r_qVQALYAuVyNnU8PLz_m-mYRBRuN7VKfzdUFA-SAjawZQ_4XZW-cWw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>609946149</pqid></control><display><type>article</type><title>Diagnosis and management of chronic ITP: comments from an ICIS expert group</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Grainger, John David ; Bolton-Maggs, Paula H. B ; Godeau, Bertrand ; Bussel, Jim ; Donato, Hugo ; Elalfy, Mohsen ; Hainmann, Ina ; Matzdorff, Axel ; Müller-Beissenhirtz, Hannes ; Rovó, Alicia ; Tichelli, Andre</creator><creatorcontrib>Grainger, John David ; Bolton-Maggs, Paula H. B ; Godeau, Bertrand ; Bussel, Jim ; Donato, Hugo ; Elalfy, Mohsen ; Hainmann, Ina ; Matzdorff, Axel ; Müller-Beissenhirtz, Hannes ; Rovó, Alicia ; Tichelli, Andre</creatorcontrib><description>Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert Meeting on Consensus and Development of Strategies in ITP, held in Basel on September 3-5, 2009, a group of experts were tasked with reaching a consensus on some frequently asked questions relating to diagnosis and management of children and adults with chronic ITP. The content of this article is designed to provide a practical support to trained haematologists in their care of patients with chronic ITP.</description><identifier>ISSN: 0939-5555</identifier><identifier>EISSN: 1432-0584</identifier><identifier>DOI: 10.1007/s00277-010-0950-0</identifier><identifier>PMID: 20449748</identifier><language>eng</language><publisher>Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag</publisher><subject>Adult ; Antigens, Human Platelet - immunology ; Autoimmunity ; Bone Marrow - immunology ; Bone Marrow - physiopathology ; Child ; Chronic Disease ; Hematology ; Humans ; Immune thrombocytopenia ; ITP ; Medicine ; Medicine &amp; Public Health ; Oncology ; Purpura, Thrombocytopenic, Idiopathic - diagnosis ; Purpura, Thrombocytopenic, Idiopathic - immunology ; Purpura, Thrombocytopenic, Idiopathic - physiopathology ; Purpura, Thrombocytopenic, Idiopathic - therapy ; Review Article</subject><ispartof>Annals of hematology, 2010-07, Vol.89 (1), p.11-17</ispartof><rights>Springer-Verlag 2010</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-a09fec23581604ee0235124f639c03806bffc8b02f1b61abc32fe1390586f0773</citedby><cites>FETCH-LOGICAL-c472t-a09fec23581604ee0235124f639c03806bffc8b02f1b61abc32fe1390586f0773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00277-010-0950-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00277-010-0950-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20449748$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00612996$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Grainger, John David</creatorcontrib><creatorcontrib>Bolton-Maggs, Paula H. B</creatorcontrib><creatorcontrib>Godeau, Bertrand</creatorcontrib><creatorcontrib>Bussel, Jim</creatorcontrib><creatorcontrib>Donato, Hugo</creatorcontrib><creatorcontrib>Elalfy, Mohsen</creatorcontrib><creatorcontrib>Hainmann, Ina</creatorcontrib><creatorcontrib>Matzdorff, Axel</creatorcontrib><creatorcontrib>Müller-Beissenhirtz, Hannes</creatorcontrib><creatorcontrib>Rovó, Alicia</creatorcontrib><creatorcontrib>Tichelli, Andre</creatorcontrib><title>Diagnosis and management of chronic ITP: comments from an ICIS expert group</title><title>Annals of hematology</title><addtitle>Ann Hematol</addtitle><addtitle>Ann Hematol</addtitle><description>Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert Meeting on Consensus and Development of Strategies in ITP, held in Basel on September 3-5, 2009, a group of experts were tasked with reaching a consensus on some frequently asked questions relating to diagnosis and management of children and adults with chronic ITP. The content of this article is designed to provide a practical support to trained haematologists in their care of patients with chronic ITP.</description><subject>Adult</subject><subject>Antigens, Human Platelet - immunology</subject><subject>Autoimmunity</subject><subject>Bone Marrow - immunology</subject><subject>Bone Marrow - physiopathology</subject><subject>Child</subject><subject>Chronic Disease</subject><subject>Hematology</subject><subject>Humans</subject><subject>Immune thrombocytopenia</subject><subject>ITP</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Purpura, Thrombocytopenic, Idiopathic - diagnosis</subject><subject>Purpura, Thrombocytopenic, Idiopathic - immunology</subject><subject>Purpura, Thrombocytopenic, Idiopathic - physiopathology</subject><subject>Purpura, Thrombocytopenic, Idiopathic - therapy</subject><subject>Review Article</subject><issn>0939-5555</issn><issn>1432-0584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kcFvFCEUxomxsWv1D_CixJMeRt8DBgZvzartxk00aXsmDIXpNDvDCjtG_3uZTG0TD-UAL4_f98HLR8grhA8IoD5mAKZUBQgV6LpsT8gKBWcV1I14Slagua7qso7J85xvAZA1gj0jxwyE0Eo0K_Ltc2-7MeY-Uzte08GOtvODHw80BupuUhx7RzeXPz5RF4e5n2lIcSgw3aw3F9T_3vt0oF2K0_4FOQp2l_3Lu_OEXH39crk-r7bfzzbr023lhGKHyoIO3jFeNyhBeA-lRCaC5NoBb0C2IbimBRawlWhbx1nwyHUZSgZQip-Q94vvjd2ZfeoHm_6YaHtzfro1cw9AItNa_sLCvlvYfYo_J58PZuiz87udHX2cskHFGYdGNbPt2__Q2zilsUxiJGgtJApdIFwgl2LOyYf7DyCYORSzhGJKKGYOxUDRvL4zntrBX98r_qVQALYAuVyNnU8PLz_m-mYRBRuN7VKfzdUFA-SAjawZQ_4XZW-cWw</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>Grainger, John David</creator><creator>Bolton-Maggs, Paula H. B</creator><creator>Godeau, Bertrand</creator><creator>Bussel, Jim</creator><creator>Donato, Hugo</creator><creator>Elalfy, Mohsen</creator><creator>Hainmann, Ina</creator><creator>Matzdorff, Axel</creator><creator>Müller-Beissenhirtz, Hannes</creator><creator>Rovó, Alicia</creator><creator>Tichelli, Andre</creator><general>Berlin/Heidelberg : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope></search><sort><creationdate>20100701</creationdate><title>Diagnosis and management of chronic ITP: comments from an ICIS expert group</title><author>Grainger, John David ; Bolton-Maggs, Paula H. B ; Godeau, Bertrand ; Bussel, Jim ; Donato, Hugo ; Elalfy, Mohsen ; Hainmann, Ina ; Matzdorff, Axel ; Müller-Beissenhirtz, Hannes ; Rovó, Alicia ; Tichelli, Andre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-a09fec23581604ee0235124f639c03806bffc8b02f1b61abc32fe1390586f0773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Antigens, Human Platelet - immunology</topic><topic>Autoimmunity</topic><topic>Bone Marrow - immunology</topic><topic>Bone Marrow - physiopathology</topic><topic>Child</topic><topic>Chronic Disease</topic><topic>Hematology</topic><topic>Humans</topic><topic>Immune thrombocytopenia</topic><topic>ITP</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Purpura, Thrombocytopenic, Idiopathic - diagnosis</topic><topic>Purpura, Thrombocytopenic, Idiopathic - immunology</topic><topic>Purpura, Thrombocytopenic, Idiopathic - physiopathology</topic><topic>Purpura, Thrombocytopenic, Idiopathic - therapy</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grainger, John David</creatorcontrib><creatorcontrib>Bolton-Maggs, Paula H. B</creatorcontrib><creatorcontrib>Godeau, Bertrand</creatorcontrib><creatorcontrib>Bussel, Jim</creatorcontrib><creatorcontrib>Donato, Hugo</creatorcontrib><creatorcontrib>Elalfy, Mohsen</creatorcontrib><creatorcontrib>Hainmann, Ina</creatorcontrib><creatorcontrib>Matzdorff, Axel</creatorcontrib><creatorcontrib>Müller-Beissenhirtz, Hannes</creatorcontrib><creatorcontrib>Rovó, Alicia</creatorcontrib><creatorcontrib>Tichelli, Andre</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Annals of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grainger, John David</au><au>Bolton-Maggs, Paula H. B</au><au>Godeau, Bertrand</au><au>Bussel, Jim</au><au>Donato, Hugo</au><au>Elalfy, Mohsen</au><au>Hainmann, Ina</au><au>Matzdorff, Axel</au><au>Müller-Beissenhirtz, Hannes</au><au>Rovó, Alicia</au><au>Tichelli, Andre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis and management of chronic ITP: comments from an ICIS expert group</atitle><jtitle>Annals of hematology</jtitle><stitle>Ann Hematol</stitle><addtitle>Ann Hematol</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>89</volume><issue>1</issue><spage>11</spage><epage>17</epage><pages>11-17</pages><issn>0939-5555</issn><eissn>1432-0584</eissn><abstract>Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert Meeting on Consensus and Development of Strategies in ITP, held in Basel on September 3-5, 2009, a group of experts were tasked with reaching a consensus on some frequently asked questions relating to diagnosis and management of children and adults with chronic ITP. The content of this article is designed to provide a practical support to trained haematologists in their care of patients with chronic ITP.</abstract><cop>Berlin/Heidelberg</cop><pub>Berlin/Heidelberg : Springer-Verlag</pub><pmid>20449748</pmid><doi>10.1007/s00277-010-0950-0</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0939-5555
ispartof Annals of hematology, 2010-07, Vol.89 (1), p.11-17
issn 0939-5555
1432-0584
language eng
recordid cdi_hal_primary_oai_HAL_hal_00612996v1
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Antigens, Human Platelet - immunology
Autoimmunity
Bone Marrow - immunology
Bone Marrow - physiopathology
Child
Chronic Disease
Hematology
Humans
Immune thrombocytopenia
ITP
Medicine
Medicine & Public Health
Oncology
Purpura, Thrombocytopenic, Idiopathic - diagnosis
Purpura, Thrombocytopenic, Idiopathic - immunology
Purpura, Thrombocytopenic, Idiopathic - physiopathology
Purpura, Thrombocytopenic, Idiopathic - therapy
Review Article
title Diagnosis and management of chronic ITP: comments from an ICIS expert group
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A55%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20and%20management%20of%20chronic%20ITP:%20comments%20from%20an%20ICIS%20expert%20group&rft.jtitle=Annals%20of%20hematology&rft.au=Grainger,%20John%20David&rft.date=2010-07-01&rft.volume=89&rft.issue=1&rft.spage=11&rft.epage=17&rft.pages=11-17&rft.issn=0939-5555&rft.eissn=1432-0584&rft_id=info:doi/10.1007/s00277-010-0950-0&rft_dat=%3Cproquest_hal_p%3E2080619651%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=609946149&rft_id=info:pmid/20449748&rfr_iscdi=true